Cargando…

Tumour necrosis factor gene polymorphisms in Egyptian patients with rheumatoid arthritis and their relation to disease activity and severity

AIM OF THE STUDY: The present case control study was conducted to assess the association of LTA 252 A>G, TNF-α 308 G>A, and TNF-α 1031 T>C gene polymorphisms with rheumatoid arthritis (RA), and their involvement in disease activity and severity. MATERIAL AND METHODS: A total of 70 Egyptians...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaghlol, Heba M., Abdelshafy, Sanaa, Mohamed, Rabab A., Abdelaleem, Enas A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Polish Society of Experimental and Clinical Immunology 2019
Materias:	Clinical Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953370/ https://www.ncbi.nlm.nih.gov/pubmed/31933537 http://dx.doi.org/10.5114/ceji.2019.89602

Ejemplares similares

MiR-146a and miR-155 polymorphisms in Egyptian patients with Behcet’s disease
por: Shaker, Olfat G., et al.
Publicado: (2021)

Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor α levels in patients with periodontitis and rheumatoid arthritis
por: Kaczyński, Tomasz, et al.
Publicado: (2019)

Association of the polymorphisms of TRAF1 (rs10818488) and TNFAIP3 (rs2230926) with rheumatoid arthritis and systemic lupus erythematosus and their relationship to disease activity among Egyptian patients
por: Moaaz, Mai, et al.
Publicado: (2016)

Identification of a Human SOCS1 Polymorphism That Predicts Rheumatoid Arthritis Severity
por: Lamana, Amalia, et al.
Publicado: (2020)

Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis
por: Low, Audrey S L, et al.
Publicado: (2017)

The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
por: Harrold, Leslie R, et al.
Publicado: (2015)

Genetic association of interleukin 18 (-607C/A, rs1946518) single nucleotide polymorphism with asthmatic children, disease severity and total IgE serum level
por: Ezzat, Dina A., et al.
Publicado: (2019)

Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
por: Glossop, John R, et al.
Publicado: (2005)

High serum leptin and adiponectin levels as biomarkers of disease progression in Egyptian patients with active systemic lupus erythematosus
por: Kamel, Shaimaa M, et al.
Publicado: (2023)

Spectral-Domain Optical Coherence Tomography of Preclinical Chloroquine Maculopathy in Egyptian Rheumatoid Arthritis Patients
por: Allam, Riham S. H. M., et al.
Publicado: (2015)

Recombinant interferon alpha 2b in rheumatoid arthritis: good antigen for rheumatoid arthritis antibodies
por: Ali Khan, Wahid
Publicado: (2018)

Cost–utility of different treatment strategies after the failure of tumour necrosis factor inhibitor in rheumatoid arthritis in the Finnish setting
por: Hallinen, Taru A., et al.
Publicado: (2010)

Evaluation of the adenosine deaminase (ADA) G22A gene polymorphism with recurrent spontaneous abortion among Egyptian patients
por: Farhan, Hanan Mohamed, et al.
Publicado: (2017)

Association of SIRT-1 Gene Polymorphism and Vitamin D Level in Egyptian Patients With Rheumatoid Arthritis
por: Sabry, Dina, et al.
Publicado: (2018)

Shared epitope and polymorphism of MICA and NKG2D encoding genes in Greek and Polish patients with rheumatoid arthritis
por: Wielińska, Joanna, et al.
Publicado: (2021)

TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade
por: van Kuijk, A W R, et al.
Publicado: (2009)

Rheumatoid arthritis study of the Egyptian College of Rheumatology (ECR): nationwide presentation and worldwide stance
por: Gheita, Tamer A., et al.
Publicado: (2023)

Overnight variations in cortisol, interleukin 6, tumour necrosis factor α and other cytokines in people with rheumatoid arthritis
por: Perry, M G, et al.
Publicado: (2009)

Association of integrin-β2 polymorphism and expression with the risk of rheumatoid arthritis and osteoarthritis in Egyptian patients
por: Selim, Aliaa M., et al.
Publicado: (2023)

Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
por: Leandro, Maria J
Publicado: (2009)

Soluble tumour necrosis factor receptor I is a promising early indicator of complicated clinical outcome in patients following severe trauma
por: BINKOWSKA, ANETA M., et al.
Publicado: (2020)

Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor–treated rheumatoid arthritis patients
por: Hamann, Philip D H, et al.
Publicado: (2019)

Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis
por: Takeuchi, Tsutomu, et al.
Publicado: (2011)

Lipocalin 2 as a clinical significance in rheumatoid arthritis
por: Gulkesen, Arif, et al.
Publicado: (2017)

Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis
por: Klaasen, R., et al.
Publicado: (2012)

The Prognostic Significance of TET2 Single Nucleotide Polymorphism in Egyptian Chronic Myeloid Leukemia
por: Hamed, Nahla A., et al.
Publicado: (2020)

Tumour necrosis factor gene polymorphisms and migraine in Greek children
por: Pappa, Styliani, et al.
Publicado: (2010)

Effect of Epstein-Barr Virus DNA on the Incidence and Severity of Arthritis in a Rheumatoid Arthritis Mouse Model
por: Fadlallah, Sukayna, et al.
Publicado: (2021)

Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis
por: Potter, C, et al.
Publicado: (2009)

Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis
por: Wijbrandts, C A, et al.
Publicado: (2008)

Association between TNF-α, Interleukin-18 Polymorphisms and Risk of Hepatocellular Carcinoma in Egyptian patients
por: Sharafelldin, Heba, et al.
Publicado: (2021)

Long Non-coding RNAs Genes Polymorphisms and Their Expression Levels in Patients With Rheumatoid Arthritis
por: Zhang, Tian-Ping, et al.
Publicado: (2019)

Vitamin D Metabolic Pathway Genes Polymorphisms and Their Methylation Levels in Association With Rheumatoid Arthritis
por: Zhang, Tian-Ping, et al.
Publicado: (2021)

Exploration of the association between the single-nucleotide polymorphism of co-stimulatory system and rheumatoid arthritis
por: Chen, Ding-Ping, et al.
Publicado: (2023)

Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis—a proof of principle and exploratory trial: is dose tapering practical in good responders?
por: Ibrahim, Fowzia, et al.
Publicado: (2017)

Inhibition of Glycolysis Reduces Disease Severity in an Autoimmune Model of Rheumatoid Arthritis
por: Abboud, Georges, et al.
Publicado: (2018)

The Association Between Interleukin 1 Beta Promoter Polymorphisms And Keratoconus Incidence And Severity In An Egyptian Population
por: Nabil, Karim Mahmoud, et al.
Publicado: (2019)

Serum Tumor Necrosis Factor-Alpha as a Competent Biomarker for Evaluation of Disease Activity in Early Rheumatoid Arthritis
por: Inam Illahi, Mehreen, et al.
Publicado: (2021)

Study of selective immunoglobulin A deficiency among Egyptian patients with food allergy
por: SHAHIN, RASHA YOUSSEF, et al.
Publicado: (2020)

Commentary: Long Non-Coding RNA Gene Polymorphisms and Their Expression Levels in Patients With Rheumatoid Arthritis
por: Hernández-Bello, Jorge, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qov3im8aanctku05ef6uvuspn8